If you're looking for DTI codes, IGN's got you covered! In this article, you'll find a list of all the active and working Dress to Impress codes in March 2026 that you can redeem for free rewards and ...

What are the new Where Winds Meet codes? Though you won't struggle to find Jade Fish and all other manner of items scattered across the world in your first run through the regions of Qinghe and ...

Add Yahoo as a preferred source to see more of our stories on Google. About a week remains to comment on Public Service Company of Oklahoma's application for an air quality permit at Northeastern ...

WASHINGTON, Feb 11 (Reuters) - The U.S. Department of Commerce on Wednesday announced a $252 million settlement with Applied Materials (AMAT.O), opens new tab for illegally exporting chipmaking ...

CAMBRIDGE, England & DETROIT--(BUSINESS WIRE)--Cycle Group Holdings Limited (“Cycle”) is delighted to announce it has completed the acquisition of NASDAQ-listed Applied Therapeutics, Inc. (NASDAQ: ...

The code injection flaws allow for unauthenticated remote code execution on Ivanti Endpoint Manager Mobile deployments, but also endanger connected Ivanti Sentry mobile traffic gateways. IT software ...

TULSA, Okla. — Two separate billing problems at Public Service Company of Oklahoma caused confusion and frustration for customers, including one that left over 1,300 people without electricity during ...

The Oklahoma Corporation Commission approves PSO’s request to purchase a power plant in Jenks. PSO first asked OCC to buy the Green Country Power Plant from Tokyo-based J-Power back in September. The ...

The data center developer enjoys an unusually high level of demand visibility. Applied Digital is transitioning from construction to recurring revenue generation. Management expects to reach $1 ...

Applied Digital boasts an exceptionally strong long-term demand visibility. The company is focused on rapidly expanding its data center capacity to meet surging demand. Applied Digital has also ...

Cycle Pharmaceuticals is circling up Applied Therapeutics, acquiring the rare disease biotech after an extremely tumultuous year for the latter that began with an FDA rejection at the end of 2024.